Antipsychotic News and Research

RSS
Antipsychotics are medicines used to treat the symptoms of mental disorders such as schizophrenia, depression, bipolar disorder (sometimes called manic-depressive illness), anxiety disorders, and attention deficit-hyperactivity disorder (ADHD). Sometimes medications are used with other treatments such as psychotherapy.
PTSD and psychoactive drugs linked to increased risk for dementia

PTSD and psychoactive drugs linked to increased risk for dementia

Experts find benefits of antipsychotic medications to be much greater than side effects

Experts find benefits of antipsychotic medications to be much greater than side effects

Powerful pain medicine may help reduce vision damage of glaucoma

Powerful pain medicine may help reduce vision damage of glaucoma

Study shows possibility to reduce antipsychotic use among nursing home residents with dementia

Study shows possibility to reduce antipsychotic use among nursing home residents with dementia

FDA grants approval for first drug to treat adults with tardive dyskinesia

FDA grants approval for first drug to treat adults with tardive dyskinesia

New drug can reduce tardive dyskinesia in patients with schizophrenia, mood disorder

New drug can reduce tardive dyskinesia in patients with schizophrenia, mood disorder

Study provides new insights into side effects of antipsychotics

Study provides new insights into side effects of antipsychotics

High-dose B vitamins can effectively reduce schizophrenia symptoms, research finds

High-dose B vitamins can effectively reduce schizophrenia symptoms, research finds

People with schizophrenia more likely to have diabetes than general population

People with schizophrenia more likely to have diabetes than general population

Delirium can be deadly threat to long-term care residents, review finds

Delirium can be deadly threat to long-term care residents, review finds

Biological Psychiatry special issue highlights role of dopamine signaling in schizophrenia

Biological Psychiatry special issue highlights role of dopamine signaling in schizophrenia

Two research studies on new molecules could potentially treat Alzheimer's disease

Two research studies on new molecules could potentially treat Alzheimer's disease

Study highlights importance of treating mental-health problems to reduce community violence

Study highlights importance of treating mental-health problems to reduce community violence

Antipsychotic drug use linked to 60% increased risk of mortality among people with Alzheimer's disease

Antipsychotic drug use linked to 60% increased risk of mortality among people with Alzheimer's disease

Women with dementia receive less health monitoring than men, UCL research reveals

Women with dementia receive less health monitoring than men, UCL research reveals

Scientists identify microrna that provides clues for quieting auditory hallucinations of schizophrenia

Scientists identify microrna that provides clues for quieting auditory hallucinations of schizophrenia

Personalized medicine may offer solution for treatment of psychiatric disturbances

Personalized medicine may offer solution for treatment of psychiatric disturbances

Lack of shrinkage in the hippocampus may help predict people at risk for dementia with Lewy bodies

Lack of shrinkage in the hippocampus may help predict people at risk for dementia with Lewy bodies

Lack of brain shrinkage may help identify people at risk for dementia with Lewy bodies

Lack of brain shrinkage may help identify people at risk for dementia with Lewy bodies

Folinic acid treatment could help improve language and communication skills of children with ASD

Folinic acid treatment could help improve language and communication skills of children with ASD

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.